Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma-Reference-Cited by-同舟云学术

Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma

Published:2014-11-17 Issue:12 Volume:124 Page:5145-5158
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Kim Jihun,Fox Cameron,Peng Shouyong,Pusung Mark,Pectasides Eirini,Matthee Eric,Hong Yong Sang,Do In-Gu,Jang Jiryeon,Thorner Aaron R.,Van Hummelen Paul,Rustgi Anil K.,Wong Kwok-Kin,Zhou Zhongren,Tang Ping,Kim Kyoung-Mee,Lee Jeeyun,Bass Adam J.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference55 articles.

1. Global Patterns of Cancer Incidence and Mortality Rates and Trends

2. Epidemiology and Pathogenesis of Esophageal Cancer

3. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

4. Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

5. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Personalized Oncology;Cancers;2024-08-16

2. Resistance to Anti-HER2 Therapies in Gastrointestinal Malignancies;Cancers;2024-08-15

3. HER2-targeted therapies beyond breast cancer — an update;Nature Reviews Clinical Oncology;2024-07-22

4. Clinical application of targeted tumour sequencing tests for detecting ERBB2 amplification and optimizing anti-HER2 therapy in gastric cancer;BMC Cancer;2024-06-11

5. Molecular Landscape and Clinical Implication of CCNE1-amplified Esophagogastric Cancer;Cancer Research Communications;2024-06-03